PepGen Inc., (PEPG): Price and Financial Metrics
PEPG Price/Volume Stats
| Current price | $1.50 | 52-week high | $19.30 |
| Prev. close | $1.42 | 52-week low | $0.88 |
| Day low | $1.36 | Volume | 174,600 |
| Day high | $1.52 | Avg. volume | 1,728,827 |
| 50-day MA | $1.43 | Dividend yield | N/A |
| 200-day MA | $4.28 | Market Cap | 49.08M |
PEPG Stock Price Chart Interactive Chart >
PepGen Inc., (PEPG) Company Bio
PepGen Inc., a clinical-stage biotechnology company, focuses on the development of oligonucleotide therapeutics for use in the treatment of severe neuromuscular and neurologic diseases. The company's lead product candidate is PGN-EDO51, an EDO peptide in Phase I clinical trials to treat individuals with Duchenne muscular dystrophy (DMD). It is also developing PGN-EDODM1, an EDO peptide-conjugated PMO for the treatment of myotonic dystrophy type 1, as well as EDO therapeutic candidates, such as PGN-EDO53, PGN-EDO45, and PGN-EDO44 for the treatment of DMD. The company was founded in 2018 and is headquartered in Cambridge, Massachusetts.
PEPG Latest News Stream
| Event/Time | News Detail | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
PEPG Price Returns
| 1-mo | -2.60% |
| 3-mo | -34.92% |
| 6-mo | -72.63% |
| 1-year | -90.95% |
| 3-year | -86.38% |
| 5-year | N/A |
| YTD | -60.42% |
| 2024 | -44.26% |
| 2023 | -49.14% |
| 2022 | N/A |
| 2021 | N/A |
| 2020 | N/A |